Breast Ductal Carcinoma in Situ
📧 Sign up to get email alerts when something new happens for Breast Ductal Carcinoma in Situ.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-19Clinical Trial Results: Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study [Phase 2]
Phase 2 clinical trial evaluating a volumetric specimen imager for intraoperative imaging in breast cancer and ductal carcinoma in situ; res…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction [Phase 2]
A Phase 2 clinical trial is recruiting to evaluate low-dose tamoxifen with or without omega-3 fatty acids for breast cancer risk reduction i…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating supplemental topical agents for the treatment of acute radiation dermatitis in patients with breast cancer…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer [Phase 2]
Phase 2 trial assessing nelipepimut-S plus GM-CSF vaccine therapy for breast ductal carcinoma in situ has been completed with results posted…
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer [Phase 1]
Phase 1 trial evaluating bexarotene for preventing breast cancer in high-risk individuals; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ [Phase 3]
Phase 3 trial comparing radiotherapy to low-dose tamoxifen after breast-conserving surgery for low-risk breast ductal carcinoma in situ (DCI…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS) [Phase 2]
Phase 2 pilot trial evaluating fulvestrant in breast ductal carcinoma in situ was terminated, with results posted in 2012.